Citation: | SHANG Ying, ZHAO Liyuan, LU Jingkun. Relationship between inflammatory cytokines and gastric cancer[J]. Journal of China Pharmaceutical University, 2015, 46(1): 123-128. DOI: 10.11665/j.issn.1000-5048.20150119 |
[1] |
Guggenheim DE,Shah MA.Gastric cancer epidemiology and risk factors[J].J Surg Oncol,2013,107(3):230-236.
|
[2] |
Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
|
[3] |
Ferro A,Peleteiro B,Malvezzi M,et al.Worldwide trends in gastric cancer mortality(1980-2011),with predictions to 2015,and incidence by subtype[J].Eur J Cancer,2014,50(7):1330-1344.
|
[4] |
Shi YY,Ding SG.Progress in the etiology and pathogenesis of gastric cancer[J].Chin J Clinicians(Electron Ed)(中华临床医师杂志 电子版),2013,7(19):7941-7944.
|
[5] |
Nam SY,Ko YS,Jung J,et al.A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis[J].Br J Cancer,2011,104(1):166-174.
|
[6] |
Kang MH,Oh SC,Lee HJ,et al.Metastatic function of BMP- 2 in gastric cancer cells:the role of PI3K/AKT,MAPK,the NF-κB pathway,and MMP-9 expression[J].Exp Cell Res,2011,317(12):1746-1762.
|
[7] |
Okamoto W,Okamoto I,Arao T,et al.Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells[J].Br J Cancer,2011,105(3):407-412.
|
[8] |
Chen J,Wang J,Lin L,et al.Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer[J].Mol Cancer Ther,2012,11(2):277-287.
|
[9] |
Xiong H,Du W,Wang JL,et al.Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer[J].J Mol Med(Berl),2012,90(9):1037-1046.
|
[10] |
Carmi Y,Dotan S,Rider P,et al.The role of IL-1β in the early tumor cell-induced angiogenic response[J].J Immunol,2013,190(7):3500-3509.
|
[11] |
Poeck H,Bscheider M,Gross O,et al.Recognition of RNA virus by RIG-I results in activation of CARD9and inflammasome signaling for interleukin 1 beta production[J].Nat Immunol,2010,11(1):63-69.
|
[12] |
Santos JC,Ladeira MS,Pedrazzoli J Jr,et al.Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population[J].Braz J Med Biol Res,2012,45(9):811-817.
|
[13] |
Martinez-Carrillo DN,Garza-Gonzalez E,Betancourt-Linares R,et al.Association of IL1B-511C/-31T haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and chronic gastritis[J].BMC Gastroenterol,2010,10:126.
|
[14] |
Xue H,Lin B,Ni P,et al.Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk:a meta-analysis[J].J Gastroenterol Hepatol,2010,25(10):1604-1617.
|
[15] |
Bonequi P,Meneses-González F,Correa P,et al.Risk factors for gastric cancer in Latin America:a meta-analysis[J].Cancer Causes Control,2013,24(2):217-231.
|
[16] |
Gilmore TD.Introduction to NF-KB:players,pathways,perspective[J].Oncoqene,2006,25(51):6680-6684.
|
[17] |
Canedo P,Durães C,Pereira F,et al.Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma[J].Cancer Epidemiol Biomarkers Prev,2008,17(9):2416-2420.
|
[18] |
Li DB.Detection and significance of TNF-a and IL-8 in gastric cancer patients serum[J].J Changzhi Med Coll(长治医学院学报),2010,24(6):404-407.
|
[19] |
Melo Barbosa HP,Martins LC,Dos Santos SE,et al.Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population[J].World J Gastroenterol,2009, 15(12):1465-1471.
|
[20] |
Rokkas T,Sechopoulos P,Pistiolas D,et al.Population differences concerning TNF-α gene polymorphisms in gastric carcinogenesis based on meta-analysis[J].Ann Gastroenterol,2014,27(2):139-148.
|
[21] |
Kuai WX,Wang Q,Yang XZ,et al.Interleukin-8 associates with adhesion,migration,invasion and chemosensitivity of human gastric cancer cells[J].World J Gastroenterol,2012, 18(9):979-985.
|
[22] |
Yamada S,Kato S,Matsuhisa T,et al.Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer[J].World J Gastroenterol,2013,19(19):2941-2949.
|
[23] |
Gabellini C,Trisciuoglio D,Desideri M,et al.Functional activity of CXCL8 receptors,CXCR1 and CXCR2,on human malignant melanoma progression[J].Eur J Cancer,2009,45(14):2618-2627.
|
[24] |
Kitadai Y,Haruma K,Mukaida N,et al.Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8[J].Clin Cancer Res,2000,6(7):2735-2740.
|
[25] |
Christofakis EP,Miyazaki H,Rubink DS,et al.Roles of CXCL8 in squamous cell carcinoma proliferation and migration[J].Oral Oncol,2008,44(10):920-926.
|
[26] |
Wu S,Shang H,Cui L,et al.Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis[J].Mol Cell Biochem,2013,375(1/2):69-79.
|
[27] |
Martin D,Galisteo R,Gutkind JS.CXCL8/IL8 stimulates vascular endothelial growth factor(VEGF)expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM(Carma3/Bcl10/Malt1)complex[J].J Biol Chem,2009,284(10):6038-6042.
|
[28] |
Li A,Dubey S,Varney ML,et al.IL-8 directly enhanced endothelial cell survival,proliferation,and matrix metalloproteinases production and regulated angiogenesis[J].J Immunol,2003,170(6):3369-3376.
|
[29] |
Cai X,Hu W,Zhang B,et al.Genotyping of IL-8-251 T>A yields prognostic information in patients with gastric carcinoma[J].Biomarkers,2013,18(7):559-564.
|
[30] |
Song JH,Kim SG,Jung SA,et al.The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans[J].Cytokine,2010,51(2):158-165.
|
[31] |
Fabris RC,Rasmussen LT,Neto AC,et al.Interleukin-8-251 T>A polymorphism and Helicobacter pylori[J].Arq Catar Med,2012,40(3):25-29.
|
[32] |
Cheng HH,Chang CS,Wang HJ,et al.Interleukin-1β and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients[J].J Gastroenterol Hepatol,2010,25(8):1443-1451.
|
[33] |
Wang N,Zhou R,Wang C,et al.-251 T/A polymorphism of the interleukin-8 gene and cancer risk:a HuGE review and meta-analysis based on 42 casecontrol studies[J].Mol Biol Rep, 2012,39(3):2831-2841.
|
[34] |
Derynck R,Miyazono K.The TGF-β Family[M].NY:Cold Spring Harbor Laboratory Press,2008:29-43.
|
[35] |
Derynck R,Akhurst RJ.Differentiation plasticity regulated by TGF-beta family proteins in development and disease[J].Nat Cell Biol,2007,9(9):1000-1004.
|
[36] |
Kamato D,Burch ML,Piva TJ,et al.Transforming growth factor-β signalling:role and consequences of Smad linker region phosphorylation[J].Cell signal,2013,25(10):2017-2024.
|
[37] |
Jo Y,Han SU,Kim YJ,et al.Suppressed gastric mucosal TGF-β1 increases susceptibility to H.pylori-induced gastric inflammation and ulceration:a stupid host defense response[J].Gut Liver,2010,4(1):43-53.
|
[38] |
Yuan XL,Chen L,Zhang TT,et al.Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1[J].World J Gastroenterol,2011,17(15):2019-2027.
|
[39] |
Lv ZD,Na D,Liu FN,et al.Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis[J].J Exp Clin Cancer Res,2010,29(1):139.
|
[40] |
Mocellin S,Marincola FM,Young HA.Interleukin-10 and the immune response against cancer:a counterpoint[J].J Leukoc Biol,2005,78(5):1043-1051.
|
[41] |
Bodger K,Wyatt JI,Heatley RV.Gastric mucosal secretion of interleukin-10:relations to histopathology,Helicobacter pylori status,and tumour necrosis factor-alpha secretion[J].Gut,1997,40:739-744.
|
[42] |
De Vita F,Orditura M,Galizia G,et al.Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies[J].Cancer,1999,86(10):1936-1943.
|
[43] |
Ono S,Tsujimoto H,Hiraki S,et al.Sex differences in cytokine produetion and surface antigen expression of peripheral blood mononuclear cells after surgery[J].Am J Surg,2005,190(3):439-44.
|
[44] |
Liu J,Song B,Wang JL,et al.Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer[J].World J Gastroenterol,2011,17(10):1362-1367.
|
[45] |
Zhuang W,Wu XT,Zhou Y,et al.Interleukin10-592 promoter polymorphism associated with gastric cancer among Asians:a meta-analysis of epidemiologic studies[J].Dig Dis Sci,2010,55(6):1525-1532.
|
[46] |
Chiurillo MA.Role of gene polymorphisms in gastric cancer and its precursor lesions:current knowledge and perspectives in Latin American countries[J].World J Gastroenterol,2014,20(16):4503-4515.
|
[47] |
Con SA,Takeuchi H,Con-Chin GR,et al.Role of bacterial and genetic factors in gastric cancer in Costa Rica[J].World J Gastroenterol,2009,15(2):211-218.
|
[48] |
de Oliveira JG,Rossi AF,Nizato DM,et al.Profiles of gene polymorphisms in cytokines and Toll-like receptors with higher risk for gastric cancer[J].Dig Dis Sci,2013,58(4):978-988.
|
[49] |
Li W,Yang Z,Huang DQ,et al.Role of Th17 and IL-17 in Helicobacter pylori-related gastric carcinogenesis[J].World Chin J Dig(世界华人消化杂志),2011,20(11):936-940.
|
[50] |
Tomita T,Jackson AM,Hida N,et al.Expression of interleukin-18,a Th1 cytokine,in human gastric mucosa is increased in Helicobacter pylori infection[J].J Infect Dis,2011,183(4):620-627.
|
[51] |
Fang RG,Wang JJ,Wang XJ,et al.Expression of IL-18 in gastric cancer and its clinical significance[J].J Chin Oncol(肿瘤学杂志),2012,18(5):333-335.
|
[52] |
Li AL,Hu ZF,Niu CY,et al.Correlation between IL-18 gene 105A/ C polymorphism and gastric cancer[J].Chin J Gerontol(中国老年学杂志),2014,34(8):2074-2076.
|
[53] |
Mitchell PJ,Afzali B,Fazekasova H,et al. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells[J].Clin Exp Immunol,2012,170(3):300-309.
|
[54] |
Jiang L,Fei XM,Ruan JS,et al.Chemotherapy on cellular immune function in patients with lung cancer[J].Zhejiang Pract Med(浙江实用医学),2013,18(6):439-442.
|
[55] |
Jiang H,Li JX.T lymphocyte subsets in peripheral blood of cancer patients[J].Lab Med Clin(检验医学与临床),2010,7(13):1361.
|
[56] |
Chen ZY,Li J.Phase targeted therapies in the treatment of gastric cancer[J].China Oncol(中国癌症杂志),2006,16(1):67-71.
|
[1] | WU Lingxi, DU Yixuan, GAO Xiangdong. Inhibitory effect of IL-27 on the overactivation of microglia[J]. Journal of China Pharmaceutical University, 2024, 55(6): 801-808. DOI: 10.11665/j.issn.1000-5048.2024022702 |
[2] | CUI Tao, WU Weidang, CI Xiaoyan, LI Wei, GUO Chuanmin, XU Jing, YI Xiulin, LIU Changxiao. Evaluation of tolerance and pharmacodynamics of nano-micelle irinotecan formulation[J]. Journal of China Pharmaceutical University, 2019, 50(2): 175-179. DOI: 10.11665/j.issn.1000-5048.20190207 |
[3] | YUE Juanjuan, CUI Hanyue, WANG Hui, YE Bin, CHEN Dingding. Protective effects of losartan potassium on 5/6 nephrectomy-induced chronic heart failure in rats[J]. Journal of China Pharmaceutical University, 2016, 47(6): 734-739. DOI: 10.11665/j.issn.1000-5048.20160617 |
[4] | JIANG Yuqiu, TANG Qiaofei, ZHANG Shuang, YAN Zhiyong. Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice[J]. Journal of China Pharmaceutical University, 2015, 46(5): 600-604. DOI: 10.11665/j.issn.1000-5048.20150514 |
[5] | CHEN Lu, LI Jiajie, PAN Cailong, ZHOU Danli, LIU Wentao, ZHANG Guangqin. Tetramethylpyrazine attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2015, 46(2): 230-234. DOI: 10.11665/j.issn.1000-5048.20150216 |
[6] | WANG Yu, ZHAO Li, MIAO Hanchi, LI Zhiyu, GUO Qinglong. Apoptosis induction of oroxylin A in human chronic myelogenous leukemia cell line K562[J]. Journal of China Pharmaceutical University, 2014, 45(2): 232-236. DOI: 10.11665/j.issn.1000-5048.20140218 |
[7] | DENG Danni, TIAN Hong, YAO Wenbing. Advances in therapeutic B-cell vaccines against chronic diseases[J]. Journal of China Pharmaceutical University, 2013, 44(5): 470-475. DOI: 10.11665/j.issn.1000-5048.20130517 |
[8] | FENG Lan-ying, HUANG Wen-ye. Expression and regulation of Bim protein in chronic myelogenous leukemia[J]. Journal of China Pharmaceutical University, 2009, 40(6): 571-575. |
[9] | Effect of Amygdalin on Chronic Gastritis and Chronic Atrophic Gastritis[J]. Journal of China Pharmaceutical University, 2002, (1): 47-49. |
[10] | Study on the Tolerance of the Rabbit Body Temperature Response to Bacterial Endotoxin[J]. Journal of China Pharmaceutical University, 1999, (3): 64-66. |